908 Devices Inc. (MASS)
Automate Your Wheel Strategy on MASS
With Tiblio's Option Bot, you can configure your own wheel strategy including MASS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol MASS
- Rev/Share 1.7356
- Book/Share 4.5052
- PB 1.496
- Debt/Equity 0.0236
- CurrentRatio 7.6174
- ROIC -0.4178
- MktCap 241704488.0
- FreeCF/Share -1.0108
- PFCF -6.7578
- PE -13.4855
- Debt/Assets 0.0192
- DivYield 0
- ROE -0.126
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 4
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
908 Devices (MASS) Upgraded to Buy: Here's What You Should Know
Published: June 26, 2025 by: Zacks Investment Research
Sentiment: Positive
908 Devices (MASS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Read More
Metropolitan Washington Council of Governments Adds 908 Devices' XplorIR to Its Hazardous Materials Response Toolkit
Published: June 03, 2025 by: Business Wire
Sentiment: Neutral
BOSTON--(BUSINESS WIRE)-- #chemID--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that the Metropolitan Washington Council of Governments (COG) has purchased eight XplorIR devices, one for each of the seven counties and District of Columbia, which comprise the COG. The devices were shipped in Q1 2025, with training taking place in Q2 2025. The handheld XplorIR device accurately detects, identifies, and quantifies 5,000 unknown gas and vapor c.
Read More
Why 908 Devices Stock Rocketed More Than 18% Higher This Week
Published: May 30, 2025 by: The Motley Fool
Sentiment: Positive
A deal agreed in a far-off country was the spark that ignited chemical analysis device maker 908 Devices (MASS -2.56%) this week. The company's stock burned hot, finishing the period over 18% higher in price, according to data compiled by S&P Global Market Intelligence.
Read More
All You Need to Know About 908 Devices (MASS) Rating Upgrade to Buy
Published: May 26, 2025 by: Zacks Investment Research
Sentiment: Positive
908 Devices (MASS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Read More
908 Devices Inc. (MASS) Q1 2025 Earnings Call Transcript
Published: May 13, 2025 by: Seeking Alpha
Sentiment: Neutral
908 Devices Inc. (NASDAQ:MASS ) Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ET Company Participants Kelly Gura - Investor Relations Kevin Knopp - Chief Executive Officer & Co-Founder Joe Griffith - Chief Financial Officer Conference Call Participants Matt Larew - William Blair Dan Arias - Stifel Puneet Souda - Leerink Partners Brendan Smith - TD Cowen Operator Hello and welcome everyone to the 908 Devices First Quarter 2025 Financial Results Conference Call. My name is Becky [ph] and I'll be your operator today.
Read More
Bet On 4 Low-Beta Stocks BWB, LRN, MASS & PM Despite Tariff Truce
Published: May 13, 2025 by: Zacks Investment Research
Sentiment: Positive
It is imperative to build a portfolio of low-beta stocks in a volatile market. Bridgewater Bancshares, Stride, 908 Devices, and Philip Morris are well-positioned to gain.
Read More
Bet On 4 Low-Beta Stocks BWB, LRN, MASS & PM Despite Tariff Truce
Published: May 13, 2025 by: Zacks Investment Research
Sentiment: Positive
It is imperative to build a portfolio of low-beta stocks in a volatile market. Bridgewater Bancshares, Stride, 908 Devices, and Philip Morris are well-positioned to gain.
Read More
908 Devices Inc. (MASS) Reports Q1 Loss, Misses Revenue Estimates
Published: May 13, 2025 by: Zacks Investment Research
Sentiment: Negative
908 Devices Inc. (MASS) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.33 per share a year ago.
Read More
908 Devices Inc. (MASS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Published: May 06, 2025 by: Zacks Investment Research
Sentiment: Negative
908 Devices (MASS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
Buy 4 Low-Beta Stocks ANIP, LRN, MASS & CTGO as Tariff Woes Continue
Published: April 23, 2025 by: Zacks Investment Research
Sentiment: Positive
It is imperative to build a portfolio of low-beta stocks in a volatile market. ANI Pharmaceuticals, Stride, 908 Devices, & Contango are well-poised to gain.
Read More
5 Top-Ranked Stocks of Nasdaq ETF Beating the Bear Market
Published: April 07, 2025 by: Zacks Investment Research
Sentiment: Negative
The tech-focused Nasdaq officially entered bear market territory on Friday, falling over 20% from its December peak.
Read More
Best Momentum Stocks to Buy for March 13th
Published: March 13, 2025 by: Zacks Investment Research
Sentiment: Positive
BK, TKOMY and MASS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 13, 2025.
Read More
908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth
Published: March 04, 2025 by: Benzinga
Sentiment: Positive
On Tuesday, Repligen Corporation RGEN purchased 908 Devices Inc.'s MASS desktop portfolio of four devices for bioprocessing process analytical technology (PAT) applications.
Read More
908 Devices to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
Published: March 03, 2025 by: Business Wire
Sentiment: Neutral
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of handheld and desktop devices for chemical analysis, today announced it will report financial results for the fourth quarter and full year 2024 before market open on Tuesday, March 4, 2025. Company management will webcast a corresponding conference call beginning at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time. Live audio of the webcast will be available on the “Investors” section of the company website at: www.908devices.
Read More
About 908 Devices Inc. (MASS)
- IPO Date 2020-12-18
- Website https://www.908devices.com
- Industry Medical - Devices
- CEO Kevin J. Knopp
- Employees 246